Response to Suarez-Kurtz's comments on strongly increased exposure of meloxicam in CYP2C93/3 individuals

Pharmacogenet Genomics. 2014 Aug;24(8):407-8. doi: 10.1097/FPC.0000000000000070.

Authors

Hye-In Lee¹, Jung-Woo Bae, Chang-Ik Choi, Yun-Jeong Lee, Ji-Yeong Byeon, Choon-Gon Jang, Seok-Yong Lee

Affiliation

¹ aDepartment of Pharmacology, School of Pharmacy, Sungkyunkwan University, Suwon bDepartment of Pharmacology, College of Pharmacy, Keimyung University, Daegu cDepartment of Pharmacotherapy, College of Pharmacy, Dongguk University, Goyang dDepartment of Pharmacotherapy, College of Pharmacy, Dankook University, Cheonan, Republic of Korea.

PMID: 25003538
DOI: 10.1097/FPC.0000000000000070

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics*
Aryl Hydrocarbon Hydroxylases / genetics*
Humans
Male
Thiazines / administration & dosage*
Thiazines / pharmacokinetics*
Thiazoles / administration & dosage*
Thiazoles / pharmacokinetics*
Thromboxane B2 / blood*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Thiazines
Thiazoles
Thromboxane B2
Aryl Hydrocarbon Hydroxylases